Revelation Biosciences - Warrant (REVBW) closed at $0.01 on October 26, 2026, down 6.7% from the previous close, on volume of 866 shares (30-day average 22,979).
Data as of October 26, 2026.
No headlines found.
No press releases found.
No news found.
Revelation Biosciences - Warrant trades on the stock market under the symbol REVBW.
As of October 27, 2026, REVBW stock price was flat at $0.01 with 8,240 million shares trading.
REVBW has a beta of 1.55, meaning it tends to be more sensitive to market movements. REVBW has a correlation of 0.01 to the broad based SPY ETF.
REVBW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, REVBW traded as high as $.04 and as low as $.00.
REVBW has underperformed the market in the last year with a return of -21.9%, while the SPY ETF gained +14.8%. In the last 3 month period, REVBW fell short of the market, returning 0.0%, while SPY returned +4.4%. However, in the most recent 2 weeks REVBW has outperformed the stock market by returning +29.9%, while SPY returned -1.1%.
REVBW support price is $.01 and resistance is $.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that REVBW shares will trade within this expected range on the day.
